Information and impact

Helping to diagnose rare genetic diseases
Your support helped Professor Kevin Hiom discover a new gene which was involved in the development of a rare genetic disease called Fanconi anemia.

Repurposing a diabetes drug for cancer treatment
Your support helped a drug for type 2 diabetes be tested in over 100 clinical trials for treatment and prevention of cancer.

Mini tumour organoids to help personalise cancer treatment
You helped fund research that allowed scientists to grow mini tumour organoids in the lab from a patient’s own cancer cells to study the disease and personalise treatment.

Drugging the 'undruggable' target in cancer
A research project you helped fund in 2013 allowed Dr Laura Soucek to develop a new treatment called omomyc, and prove that it was ready for clinical trials.

Pioneering a new laser therapy for cancer
Our research helped to discover a pioneering new treatment called photodynamic therapy which can cure cancer if it's caught early enough.

Helping to develop new blood cancer drugs
Your support helped Professor Mark Cragg discover how drugs could be used to target and destroy cancer cells and helped develop new blood cancer treatments.

Clinical trials to stop bowel cancer coming back
Your support in 2005 has helped launch clinical trials testing a promising new treatment option for people with bowel cancer.

Making the most of your donations to start new cures
How do we know that what we are doing works? We explore the average return on investment of our research funding.

Developing a new type of cancer immunotherapy
With your support Dr John Maher's impact on cancer research has led to the development of a brand new type of immunotherapy that is now in clinical trials.